- Home
- PLXS vs ITGR Comparison
PLXS vs ITGR Comparison
Compare PLXS & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLXS
- ITGR
- Stock Information
- Founded
- PLXS 1979
- ITGR 1970
- Country
- PLXS United States
- ITGR United States
- Employees
- PLXS N/A
- ITGR N/A
- Industry
- PLXS Electrical Products
- ITGR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- PLXS Technology
- ITGR Health Care
- Exchange
- PLXS Nasdaq
- ITGR Nasdaq
- Market Cap
- PLXS 3.7B
- ITGR 4.2B
- IPO Year
- PLXS 1986
- ITGR 2000
- Fundamental
- Price
- PLXS $142.76
- ITGR $104.07
- Analyst Decision
- PLXS Strong Buy
- ITGR Strong Buy
- Analyst Count
- PLXS 5
- ITGR 9
- Target Price
- PLXS $154.50
- ITGR $141.78
- AVG Volume (30 Days)
- PLXS 142.0K
- ITGR 352.3K
- Earning Date
- PLXS 10-22-2025
- ITGR 10-23-2025
- Dividend Yield
- PLXS N/A
- ITGR N/A
- EPS Growth
- PLXS 47.80
- ITGR N/A
- EPS
- PLXS 5.87
- ITGR 2.31
- Revenue
- PLXS $4,025,169,000.00
- ITGR $1,794,800,000.00
- Revenue This Year
- PLXS $3.54
- ITGR $10.92
- Revenue Next Year
- PLXS $8.27
- ITGR $7.35
- P/E Ratio
- PLXS $24.32
- ITGR $45.22
- Revenue Growth
- PLXS 2.31
- ITGR 9.64
- 52 Week Low
- PLXS $103.43
- ITGR $99.73
- 52 Week High
- PLXS $172.89
- ITGR $146.36
- Technical
- Relative Strength Index (RSI)
- PLXS 63.28
- ITGR 45.07
- Support Level
- PLXS $135.46
- ITGR $99.73
- Resistance Level
- PLXS $141.24
- ITGR $105.57
- Average True Range (ATR)
- PLXS 2.92
- ITGR 2.42
- MACD
- PLXS 0.18
- ITGR -0.10
- Stochastic Oscillator
- PLXS 93.05
- ITGR 49.89
About PLXS Plexus Corp.
Plexus Corp is a U.S based Electronic Manufacturing Services company that provides a range of services, from conceptualization and design to fulfilling orders and providing sustaining solutions, such as replenishment and refurbishment. The company's segments comprise AMER, APAC,ge and EMEA.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.